In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits for serology-based antibody detection by ELISA of patients who have been exposed to COVID-19. The development of the assays has been spearheaded by affiliate companies Gold Standard Diagnostics Inc., VIROTECH Diagnostics GmbH, NovaTec Immundiagnostica GmbH … [Read more...] about Eurofins Technologies launches multiple CE-IVD marked serologic products for the detection of antibodies in patients who have been exposed to SARS-CoV-2 (COVID-19)

Ebersberg, Germany - Eurofins Genomics Europe, a leader in genomic products and services, announces the launch of its “SARS-CoV-2 Full-length Genome Sequencing” service, a new next generation sequencing (NGS) service enabling end-to-end surveillance of the coronavirus genome sequence and mutational drift. The new service is Eurofins Genomics’ latest addition to a whole product portfolio aimed at … [Read more...] about Eurofins Genomics launches “SARS-CoV-2 Full-length Genome Sequencing” service to support researchers globally in their fight against the COVID-19 pandemic and outbreak source tracing

Viracor Eurofins received FDA EUA for its RT-PCR SARS-CoV-2 Virus LDT. Eurofins Genomics expands capacity for probes and primers production for RT-PCR SARS-CoV-2 test kits Eurofins Technologies, a fast growing provider of diagnostic technologies in the field of immunoassays and molecular detection methods, announces the launch of a range of testing kits for serology-based antibody detection by … [Read more...] about Eurofins Technologies launches multiple new products for the serologic detection of antibodies in patients who have been exposed to COVID-19

Eurofins, a global leader in testing and laboratory services, announces that its laboratories across the U.S.A., Europe and Asia are now providing a global service offer for testing, inspection and regulatory services focused on medical face masks, gloves and gowns, respiratory protective devices and equipment, its materials and components, as well as disinfectants and hand sanitizers, to serve … [Read more...] about Eurofins Scientific Offers a full range of Testing services for Personal Protective Equipment (PPEs) and Medical Devices used in the fight against the COVID pandemic

Eurofins Technologies, a fast growing provider of diagnostic technologies in the field of immunoassays and molecular detection methods, has launched GeneScan VIRSeek SARS-CoV-2 RT-PCR, an integrated solution including RNA extraction and test kits based on real-time RT-PCR (Reverse transcription polymerase chain reaction) for the detection of SARS-CoV-2 in swabs of environmental … [Read more...] about Eurofins Technologies launches testing solutions for the detection of SARS-CoV-2 on environmental surfaces

Eurofins, a global leader in testing and laboratory services, announces that, in addition to the U.S.A. and Germany, as previously communicated, it is now offering testing for detection of SARS-CoV-2 in France, Spain and Brazil with the Netherlands expected to start processing samples shortly. Global capacity created is currently around 10,000 tests per day split about equally between Europe and … [Read more...] about Eurofins Scientific Supports Healthcare Authorities in Europe, the U.S.A. and Brazil in their Fight against the COVID-19 Pandemic with Additional Testing Options and Fast Growing Capacity

Eurofins, a global leader in testing and laboratory services, announces that two of its clinical diagnostic testing laboratories in the United States now offer testing for evaluation of COVID-19. On 13 March 2020, Viracor Eurofins, one of the largest and most recognised infectious diseases testing laboratories in the U.S.A., is launching a stand-alone real time reverse transcriptase PCR assay for … [Read more...] about Eurofins Scientific Supports SARS-CoV-2 Analyses needs in the U.S.A. and in Europe with Multiple Testing Options

As a result of both the major impact of the criminal cyber-attack on Eurofins’ operations that hit many laboratories of the Group on 02 June 2019 and the first implementation of IFRS 16 on Eurofins’ accounts, FY 2019 reported results are not easily comparable with FY 2018 results. Therefore, in addition to reported and adjusted1 results, this press release also provides estimates on a comparable … [Read more...] about Eurofins delivers strong growth again in 2019